243 related articles for article (PubMed ID: 8652829)
41. A novel biphenotypic B-cell precursor leukemia cell line (NALM-29) carrying t(9;22)(q34;q11) established from a patient with acute leukemia.
Matsuo Y; Drexler HG; Takeuchi M; Orita K
Leuk Res; 1999 Aug; 23(8):731-40. PubMed ID: 10456671
[TBL] [Abstract][Full Text] [Related]
42. Characterization of acute lymphoblastic leukemia progenitor cells.
Cox CV; Evely RS; Oakhill A; Pamphilon DH; Goulden NJ; Blair A
Blood; 2004 Nov; 104(9):2919-25. PubMed ID: 15242869
[TBL] [Abstract][Full Text] [Related]
43. Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients.
Traxel S; Schadt L; Eyer T; Mordasini V; Gysin C; Munthe LA; Niggli F; Nadal D; Bürgler S
Oncogene; 2019 Mar; 38(13):2420-2431. PubMed ID: 30532071
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of T cell/B cell interaction by B-CLL cells.
Kneitz C; Goller M; Wilhelm M; Mehringer C; Wohlleben G; Schimpl A; Tony HP
Leukemia; 1999 Jan; 13(1):98-104. PubMed ID: 10049067
[TBL] [Abstract][Full Text] [Related]
45. The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
Bühring HJ; Sures I; Jallal B; Weiss FU; Busch FW; Ludwig WD; Handgretinger R; Waller HD; Ullrich A
Blood; 1995 Sep; 86(5):1916-23. PubMed ID: 7544646
[TBL] [Abstract][Full Text] [Related]
46. CD10 and CD19 fluorescence intensity of B-cell precursors in normal and leukemic bone marrow. Clinical characterization of CD10(+strong) and CD10(+weak) common acute lymphoblastic leukemia.
Rego EM; Tone LG; Garcia AB; Falcão RP
Leuk Res; 1999 May; 23(5):441-50. PubMed ID: 10374858
[TBL] [Abstract][Full Text] [Related]
47. G19.4(alpha CD3) x B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells.
Anderson PM; Crist W; Hasz D; Carroll AJ; Myers DE; Uckun FM
Blood; 1992 Dec; 80(11):2826-34. PubMed ID: 1280479
[TBL] [Abstract][Full Text] [Related]
48. Generation of potent T(h)1 responses from patients with lymphoid malignancies after differentiation of B lymphocytes into dendritic-like cells.
Mohty M; Isnardon D; Charbonnier A; Lafage-Pochitaloff M; Merlin M; Sainty D; Olive D; Gaugler B
Int Immunol; 2002 Jul; 14(7):741-50. PubMed ID: 12096033
[TBL] [Abstract][Full Text] [Related]
49. Thiorphan, an inhibitor of neutral endopeptidase/enkephalinase (CD10/CALLA) enhances cell proliferation in bone marrow cultures of patients with acute leukemia in remission.
Stanović S; Boranić M; Petrovecki M; Batinić D; Skodlar J; Nemet D; Labar B
Haematologia (Budap); 2000; 30(1):1-10. PubMed ID: 10841318
[TBL] [Abstract][Full Text] [Related]
50. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells.
Uckun FM; Gajl-Peczalska K; Myers DE; Jaszcz W; Haissig S; Ledbetter JA
Blood; 1990 Dec; 76(12):2449-56. PubMed ID: 1702326
[TBL] [Abstract][Full Text] [Related]
51. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
52. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
53. IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency.
Punnonen J; Kainulainen L; Ruuskanen O; Nikoskelainen J; Arvilommi H
Scand J Immunol; 1997 Feb; 45(2):203-12. PubMed ID: 9042433
[TBL] [Abstract][Full Text] [Related]
54. Maturation of acute T-lymphoblastic leukemia cells after CD2 ligation and subsequent treatment with interleukin-2.
Mentz F; Ouaaz F; Michel A; Blanc C; Hervé P; Bismuth G; Debré P; Merle-Béral H; Mossalayi MD
Blood; 1994 Aug; 84(4):1182-92. PubMed ID: 7519476
[TBL] [Abstract][Full Text] [Related]
55. Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibody.
Csóka M; Strauss G; Debatin KM; Moldenhauer G
Leukemia; 1996 Nov; 10(11):1765-72. PubMed ID: 8892680
[TBL] [Abstract][Full Text] [Related]
56. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
57. Significantly increased CD70 up regulation on TEL-AML positive B cell precursor acute lymphoblastic leukemia cells following CD40 stimulation.
Troeger A; Glouchkova L; Ackermann B; Escherich G; Hanenberg H; Janka G; Roettgers S; Göbel U; Dilloo D
Klin Padiatr; 2014 Nov; 226(6-7):332-7. PubMed ID: 25062112
[TBL] [Abstract][Full Text] [Related]
58. CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes.
Granziero L; Circosta P; Scielzo C; Frisaldi E; Stella S; Geuna M; Giordano S; Ghia P; Caligaris-Cappio F
Blood; 2003 Mar; 101(5):1962-9. PubMed ID: 12406905
[TBL] [Abstract][Full Text] [Related]
59. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
60. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns.
Durandy A; De Saint Basile G; Lisowska-Grospierre B; Gauchat JF; Forveille M; Kroczek RA; Bonnefoy JY; Fischer A
J Immunol; 1995 Feb; 154(4):1560-8. PubMed ID: 7530739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
